StockWatch reads on headlines that mention or impact this symbol. Publisher links open the original story.
DirectHigh impactGlobalMostly neutralGoogle News
Broad market headline - check whether risk appetite shifts. Watch .SPX, .FTSE, .N225, @CL.1 on the tape. This story mentions the symbol directly. Global wire stories can stay narrative-only or move indices if they change growth, rates, or geopolitics assumptions. Use the related…
via FinvizSanofi Faces A Proof Test As Vaccine Slump And Dupixent Slowdown Hit Q3
Watch: .SPX · .FTSE · .N225 · @CL.1
DirectHigh impactGoogle News
Broad market headline - check whether risk appetite shifts. Watch SNY, .SPX, .FTSE, .N225 on the tape. This story mentions the symbol directly. Global wire stories can stay narrative-only or move indices if they change growth, rates, or geopolitics assumptions. Use the related ti…
via Seeking AlphaSanofi: Why The Market Seems To Be Overpricing Pipeline Risk (NASDAQ:SNY)
DirectHigh impactGoogle News
Broad market headline - check whether risk appetite shifts. Watch SNY, .SPX, .FTSE, .N225 on the tape. This story mentions the symbol directly. Global wire stories can stay narrative-only or move indices if they change growth, rates, or geopolitics assumptions. Use the related ti…
via GuruFocusSanofi (SNY) Begins Construction of New Insulin Manufacturing Fa
DirectHigh impactGoogle News
Broad market headline - check whether risk appetite shifts. Watch .SPX, .FTSE, .N225, @CL.1 on the tape. This story mentions the symbol directly. Global wire stories can stay narrative-only or move indices if they change growth, rates, or geopolitics assumptions. Use the related…
via Yahoo FinanceWhich Pharma Stock Looks More Attractive: Sanofi or AbbVie?
DirectHigh impactGoogle News
Broad market headline - check whether risk appetite shifts. Watch GSK, SNY, .SPX, .FTSE on the tape. This story mentions the symbol directly. Global wire stories can stay narrative-only or move indices if they change growth, rates, or geopolitics assumptions. Use the related tick…
via Yahoo FinanceGSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential?